EE200900049A - Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina - Google Patents

Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina

Info

Publication number
EE200900049A
EE200900049A EEP200900049A EEP200900049A EE200900049A EE 200900049 A EE200900049 A EE 200900049A EE P200900049 A EEP200900049 A EE P200900049A EE P200900049 A EEP200900049 A EE P200900049A EE 200900049 A EE200900049 A EE 200900049A
Authority
EE
Estonia
Prior art keywords
stradiol
ethin
drospirenone
contraceptive
pharmaceutical composition
Prior art date
Application number
EEP200900049A
Other languages
English (en)
Inventor
Heil Wolfgang
Hilman J�rgen
Lipp Ralph
Heithecker Renate
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200900049(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Priority claimed from EEP200200110A external-priority patent/EE05128B1/et
Publication of EE200900049A publication Critical patent/EE200900049A/et
Publication of EE05317B1 publication Critical patent/EE05317B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200900049A 1999-08-31 2000-08-31 Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina EE05317B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
EEP200200110A EE05128B1 (et) 1999-08-31 2000-08-31 Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks

Publications (2)

Publication Number Publication Date
EE200900049A true EE200900049A (et) 2009-10-15
EE05317B1 EE05317B1 (et) 2010-08-16

Family

ID=26153358

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200900049A EE05317B1 (et) 1999-08-31 2000-08-31 Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina

Country Status (11)

Country Link
CN (1) CN1223350C (et)
BG (2) BG109749A (et)
CA (1) CA2382426C (et)
EE (1) EE05317B1 (et)
HR (1) HRP20020258B1 (et)
IL (2) IL197396A (et)
MX (1) MXPA02002043A (et)
NO (3) NO327588B3 (et)
RU (4) RU2269342C2 (et)
SK (1) SK287634B6 (et)
UA (1) UA81387C2 (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
WO1998004269A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen

Also Published As

Publication number Publication date
RU2449796C9 (ru) 2007-10-27
NO327588B1 (no) 2009-08-31
EE05317B1 (et) 2010-08-16
RU2449796C2 (ru) 2006-02-10
IL197396A (en) 2010-04-29
RU2482853C2 (ru) 2013-05-27
RU2010114825A (ru) 2011-10-20
BG65204B1 (bg) 2007-07-31
IL200482A0 (en) 2011-07-31
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
CN1407895A (zh) 2003-04-02
NO2010004I1 (no) 2010-03-22
UA81387C2 (en) 2008-01-10
RU2269342C9 (ru) 2007-10-27
HRP20020258A2 (en) 2005-02-28
RU2396082C2 (ru) 2010-08-10
MXPA02002043A (es) 2003-08-20
CN1223350C (zh) 2005-10-19
RU2005131868A (ru) 2007-04-20
HRP20020258B1 (hr) 2007-05-31
BG106533A (bg) 2002-10-31
NO20083854L (no) 2002-04-26
SK2572002A3 (en) 2002-11-06
NO327588B3 (no) 2011-05-16
SK287634B6 (sk) 2011-04-05
RU2269342C2 (ru) 2006-02-10
CA2382426A1 (en) 2001-03-08
NO20091809L (no) 2002-04-26

Similar Documents

Publication Publication Date Title
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0202495A3 (en) Stable medicinal compositions for oral use
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0203971A3 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents and pharmaceutical compositions containing them and their use
HUP0200879A3 (en) Pharmaceutical composition for dermal use
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0101437A3 (en) Oral pharmaceutical extended release dosage form
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
HUP0003929A3 (en) Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
EG23759A (en) Stable extended release oral dosage composition
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0103008A3 (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
HUP0400558A3 (en) Substituted benzene derivatives or salts thereof and pharmaceutical compositions containing them
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
IL200482A0 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
MF4A Right revoked following opposition or revocation
TH4A Reinstatement
MF4A Right revoked following opposition or revocation

Effective date: 20000831